Figures & data
(A) Time of approval of various cancer therapies based on US FDA approval time. (B) Timeline to show the establishment of pharmacogenetic prognostic tools.
DMET: Drug-metabolizing enzymes and transporters; HDAC: Histone deacetylase.
![Figure 1. Timeline of pharmacogenetic prognostic tools and drug development from 2000 to 2020. (A) Time of approval of various cancer therapies based on US FDA approval time. (B) Timeline to show the establishment of pharmacogenetic prognostic tools.DMET: Drug-metabolizing enzymes and transporters; HDAC: Histone deacetylase.](/cms/asset/54b386a1-cca5-46c5-82e4-ccbd37dac5bb/ipgs_a_12347087_f0001.jpg)
Register now or learn more
Free access
(A) Time of approval of various cancer therapies based on US FDA approval time. (B) Timeline to show the establishment of pharmacogenetic prognostic tools.
DMET: Drug-metabolizing enzymes and transporters; HDAC: Histone deacetylase.
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.